| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/20/1994 | EP0592903A2 Use of ancrod for the preparation of drugs for the treatment of restenosis |
| 04/20/1994 | EP0592791A2 Tricyclic compounds and peptide derivatives thereof |
| 04/20/1994 | EP0592692A1 Fed batch culture method for protein secreting cells. |
| 04/20/1994 | EP0592673A1 6(r)-l-erythro-5,6,7,8-tetrahydrobiopterin receptor |
| 04/20/1994 | EP0592634A1 Inhibitor of protein kinase c |
| 04/20/1994 | EP0592600A1 Proteins s polypeptides and uses thereof |
| 04/20/1994 | EP0592582A1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 04/20/1994 | EP0592562A1 Bmp-9 compositions |
| 04/20/1994 | EP0592557A1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 04/20/1994 | EP0592553A1 Pla2 inhibitory compounds |
| 04/20/1994 | EP0592529A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 04/20/1994 | EP0592512A1 NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS |
| 04/20/1994 | EP0592490A1 Amino acid derivative anticonvulsant |
| 04/20/1994 | EP0592480A1 Papillomavirus l2 protein |
| 04/20/1994 | EP0592478A1 Use of lipases to produce drugs |
| 04/20/1994 | EP0592464A1 Chemotactic factor |
| 04/20/1994 | EP0539408B1 Stable pharmaceutical compositions containing a fibroblast growth factor |
| 04/20/1994 | EP0408711B1 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant |
| 04/20/1994 | EP0293394B1 Novel thrombolytic proteins |
| 04/20/1994 | CN1085563A Novel peptides, the preparation and use thereof |
| 04/20/1994 | CN1085562A 7beta-substituted-4-aza-5alpha-cholestan-ones as 5-alpha-reductase inhibitors |
| 04/20/1994 | CN1085430A Composition for treating and inhibiting gastric and duodenal ulcers |
| 04/20/1994 | CA2108622A1 Growth inhibitory factor |
| 04/19/1994 | US5304724 Freeze-dried powder of glutathione, sodium bicarbonate to dissolve in I.V. solution; for intraocular surgery |
| 04/19/1994 | US5304640 DNA sequence encoding a selectin ligand |
| 04/19/1994 | US5304638 Protein separation medium |
| 04/19/1994 | US5304637 Expression and purification of human interleukin-3 and muteins thereof |
| 04/19/1994 | US5304636 Receptor for the human rhinovirus minor group |
| 04/19/1994 | US5304633 Fragments of lactoferrin having potent antimicrobial activity |
| 04/19/1994 | US5304631 Polypeptide catalyst |
| 04/19/1994 | US5304603 Polypeptide; androgen secretion stimulator |
| 04/19/1994 | US5304570 Pharmaceutical composition useful for the treatment of cardiovascular diseases |
| 04/19/1994 | US5304542 Use of platelet factor 4 to inhibit osteoblast proliferation |
| 04/19/1994 | US5304541 Methods using novel chimeric transforming growth factor-β1/β2 |
| 04/19/1994 | US5304540 Pharmaceutical bacteriocin compositions and methods for using the same |
| 04/19/1994 | US5304496 Polypeptides for treating kidney stone disease |
| 04/19/1994 | US5304482 Genetic engineering |
| 04/19/1994 | US5304474 Deactivation of killer cells or cytotoxic lymphocytes |
| 04/19/1994 | US5304473 Treating non-insulin dependent diabetes |
| 04/19/1994 | US5304464 Protein complex enhancing sperm motility |
| 04/19/1994 | US5304383 Pharmaceutical preparation based on Lys-plasminogen |
| 04/19/1994 | US5304382 Ferritin analogs |
| 04/19/1994 | US5304377 Blend of polylactic acid and glycolic acid copolymer |
| 04/19/1994 | US5304372 From blood |
| 04/19/1994 | US5304121 Catheter |
| 04/19/1994 | CA1328706C Alpha_-antitrypsin variants useful as kallikrenein inhibitors |
| 04/19/1994 | CA1328634C Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
| 04/19/1994 | CA1328625C Purification process |
| 04/19/1994 | CA1328608C Glaucoma treatment |
| 04/19/1994 | CA1328602C Hemoglobin macromolecular conjugates, their preparation process and their uses |
| 04/14/1994 | WO1994008053A1 Oligonucleotides having a conserved g4 core sequence |
| 04/14/1994 | WO1994008041A1 Inhibition of cyst formation by cytoskeletal specific drugs |
| 04/14/1994 | WO1994008040A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 04/14/1994 | WO1994008038A1 Bispecific reagents for redirected targeting of low density lipoprotein |
| 04/14/1994 | WO1994008034A1 Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient |
| 04/14/1994 | WO1994008026A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 04/14/1994 | WO1994008022A1 Vector to deliver and express foreign gene |
| 04/14/1994 | WO1994008017A1 Ptp 1d: a novel protein tyrosine phosphatase |
| 04/14/1994 | WO1994008013A1 Pilin variants and uses thereof |
| 04/14/1994 | WO1994008007A1 Trophic factor having ion channel-inducing activity in neuronal cells |
| 04/14/1994 | WO1994008006A1 Human calcitonin receptor |
| 04/14/1994 | WO1994008004A1 Therapeutic anti-hiv oligonucleotide and pharmaceutical |
| 04/14/1994 | WO1994008003A1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE |
| 04/14/1994 | WO1994007999A1 Chitosan matrices for encapsulated cells |
| 04/14/1994 | WO1994007992A1 Peptides specifically binding to plasminogen and the dna encoding such peptides |
| 04/14/1994 | WO1994007922A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/14/1994 | WO1994007921A1 Target binding polypeptide |
| 04/14/1994 | WO1994007920A1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
| 04/14/1994 | WO1994007918A1 Multimeric polyvalent antithrombotic agents |
| 04/14/1994 | WO1994007914A1 Allosteric modulators of the nmda receptor |
| 04/14/1994 | WO1994007906A1 Epidermal surface antigen and uses thereof |
| 04/14/1994 | WO1994007815A2 Small peptide anaphylatoxin receptor ligands |
| 04/14/1994 | WO1994007548A1 Method of preparing a biological adhesive enriched with platelet factors, and application |
| 04/14/1994 | WO1994007537A1 Pharmaceutical composition for site-specific release of a clot-dissolving protein |
| 04/14/1994 | WO1994007530A1 Vaccines and antigenic conjugates |
| 04/14/1994 | WO1994007528A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia-tissue factor complex |
| 04/14/1994 | WO1994007527A2 Vasoactive peptide inhibition |
| 04/14/1994 | WO1994007526A1 Insulin-like peptide |
| 04/14/1994 | WO1994007525A1 Antiviral agent |
| 04/14/1994 | WO1994007524A1 Method of treatment of arthritis with platelet factor 4 |
| 04/14/1994 | WO1994007523A1 Antimicrobial peptides |
| 04/14/1994 | WO1994007522A1 Therapeutic and diagnostic methods and compositions based on transducin-like enhancer of split proteins and nucleic acids |
| 04/14/1994 | WO1994007521A1 Methods and compositions for treatment of allergic disease |
| 04/14/1994 | WO1994007520A1 Method of treating rheumatoid arthritis with type ii collagen |
| 04/14/1994 | WO1994007519A1 Growth hormone releasing peptides |
| 04/14/1994 | WO1994007518A1 Anaphylatoxin receptor ligands containing lipophilic residues |
| 04/14/1994 | WO1994007517A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/14/1994 | WO1994007516A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
| 04/14/1994 | WO1994007515A1 Mutant tissue factor lacking factor vii activation activity |
| 04/14/1994 | WO1994007514A1 Pulmonary delivery of active fragments of parathyroid hormone |
| 04/14/1994 | WO1994007510A1 Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| 04/14/1994 | WO1994007502A1 Characterization of a chromosome 11q23 translocation breakpoint associated with acute leukemias |
| 04/14/1994 | WO1994007483A1 Benzo-fused lactams promote release of growth hormone |
| 04/14/1994 | WO1994007474A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 04/14/1994 | WO1994007473A1 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGFαPE40ab |
| 04/14/1994 | WO1994007448A1 Tissue protective and regenerative compositions |
| 04/14/1994 | WO1994007366A1 Pp14-based therapy |
| 04/14/1994 | WO1993025576A3 Peptides having platelet-derived growth factor (pdgf) activity |
| 04/14/1994 | DE4233782A1 Human embryonal kinase 2-receptor protein - useful in tumour diagnosis and therapy |
| 04/14/1994 | CA2282888A1 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides |